Anemia
Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints
Published in Cardiovascular Business Week, November 17th, 2009
Amgen (NASDAQ: AMGN) announced the publication of results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp=AE Therapy), a large, randomized, double-blind, placebo-controlled, Phase 3 pivotal study of patients with chronic kidney disease (CKD) not on dialysis, moderate anemia and type-2 diabetes. The study, published online today in the New England Journal of Medicine and presented at the annual meeting of the American Society of Nephrology (ASN), failed to meet its primary objectives of demonstrating a reduction in all-cause mortality, cardiovascular morbidity, including heart failure, heart attack, stroke, or hospitalization for myocardial ischemia, or end-stage renal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- American Psychological Association
Detroit Residents Continue to Report High Levels of Stress - American Psychological Association
Seattle Residents Continue to Report High Levels of Stress - Arrhythmia
New Research Uncovers Potential Dangers of Portable Headphones on Life-Saving Cardiac Devices - Atrial Fibrillation
Global Atrial Fibrillation Device Market to Grow by Almost 10% Through 2013 - AtriCure, Inc.
AtriCure Reports Third Quarter 2009 Financial Results - Avo Photonics
Avo Photonics and Case Western Reserve University Are Pleased to Announce the Completion of a Design and Development Contract for an Optical Coherence Tomography OCT Forward Imaging Catheter - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
